RET finger protein (RFP) belongs to the large B-box RING finger protein family and is known to become oncogenic by fusion with RET tyrosine kinase. Although RFP is reported to be a nuclear protein that is present in the nuclear matrix, its function is largely unknown. Here we show that RFP interacts with Enhancer of Polycomb (EPC) and strongly represses the gene transcription. Yeast two-hybrid assays revealed that the coiledcoil domain of RFP was associated with the EPcA domain and the carboxyl-terminal region of EPC. In addition, both proteins were co-precipitated from the lysates of human cells and mostly colocalized in the nucleus. Using the luciferase reporter-gene assay, we found that they repress the gene transcription activity independent of the differences of enhancers and promoters used, although the repressive activity of RFP was much stronger than that of EPC. The coiled-coil domain of RFP and the carboxyl-terminal region of EPC were most important for the repressive activity of each protein, whereas the EPcA domain had the transcription activating ability that is unique as the Polycomb group protein function. These results suggested that RFP may be involved in the epigenetic gene silencing mechanism cooperating with Polycomb group proteins and that EPC is a unique molecule with both repressive and transactivating activities.
RET finger protein (RFP) 1 belongs to the large B-box RING finger protein family, members of which contain a tripartite motif consisting of a RING finger, a B-box, and a coiled-coil domain with three defined helices (1) (2) (3) (4) (5) . In addition, it contains a specific carboxyl-terminal region known as the RFP domain or the B30.2-like domain (6) . RFP mRNA was detected in a variety of human and rodent tumor cell lines as well as in male germ cells at high levels (1) . It was also shown that RFP is associated with the nuclear matrix (7) and is expressed in the nuclei of various cells, including peripheral and central neurons, hepatocytes and adrenal chromaffin cells (8) , and partially colocalizes with PML and int-6 (9, 10).
There are over 200 members of the RING finger protein family reported to date, including PML, BMI1/Mel-18, RING1, and KAP-1 (11) (12) (13) . RING finger proteins are thought to play roles in the formation and architecture of large protein complexes that contribute to diverse cellular processes such as oncogenesis, apoptosis, development, and ubiquitination (11, 14) . BMI1/Mel-18 and RING1 belong to Polycomb group proteins (15, 16) , and especially RING1 was reported to form the Polycomb group protein complex with HPC2, BMI1, and HPH and repress the gene transcription (16, 17) . In addition, PML, BMI1/Mel-18, RING1 and RFP are all involved in oncogenesis by the formation of oncogenic fusion proteins (1, 18 -22) or by deregulating the expression levels of certain oncogenes (17, 23, 24) .
Polycomb group proteins have been initially identified in Drosophila as being involved in the maintenance of the correct expression pattern of homeotic genes. Polycomb group proteins form the chromatin associated-protein complexes that are involved in the epigenetic gene silencing and in the maintenance of cell type specificity (25) (26) (27) . The homologues of Polycomb group proteins were also found in other vertebrates and invertebrates such as human, mouse, chicken, Xenopus, and Caenorhabditis elegans (28) . On the other hand, epigenetic gene activation mechanism is known to be mediated by distinct protein complexes consisting of trithorax group proteins.
Enhancer of Polycomb (EPC) is a unique member of the Polycomb group proteins (29) . Although mutations in E(Pc), the Drosophila homologue of EPC, exhibit no homeotic transformations, they enhance homeotic mutations by other Polycomb group genes, such as Pc, Pcl, ph, Sce, Scm, and sxc (30, 31) . Mutations in E(Pc) also function as the strong suppressors of position-effect variegation (PEV) that is another epigenetic gene silencing mechanism and is associated with the heterochromatin formation (32, 33) . Among Polycomb group genes, only E(Pc) and Enhancer of zeste (E(z)) were shown to function as Su(var)s (suppressors of PEV) (29) . Interestingly, E(z) was reported to have both transcription activating and repressing functions and can be classified as both Polycomb and trithorax group proteins (34) . In contrast to most of other Polycomb group proteins, no interacting proteins of EPC have been found so far (28) . These results suggest that EPC may have a unique role in the gene silencing mechanisms mediated by Polycomb group proteins.
Here we report that RFP interacts with human EPC and that RFP itself functions as a strong transcriptional repressor when targeted to reporter genes. This interaction is mediated by the binding between the coiled-coil domain of RFP and the conserved EPcA domain or the carboxyl-terminal region of EPC.
Immunofluorescence study revealed that RFP mostly colocalizes with EPC in the nuclei of human cells, suggesting cooperative roles of RFP and EPC in gene silencing.
EXPERIMENTAL PROCEDURES
Plasmid Constructs-The RING finger B box region (amino acids 2 to 135), the coiled-coil domain region (amino acids 132 to 317), and the RFP domain region (amino acids 316 to 514) ( Fig. 2A) were amplified by specific primers with a flanking EcoRI site on the 5Ј primer and a BamHI site on the 3Ј primer, using the full-length human RFP cDNA as a template. The resulting PCR products were subcloned into the pGEM-T vector (Promega) and sequenced to ensure that there were no mutations due to PCR errors. Each product was subcloned into the EcoRI/BamHI sites of pAS2-1 vector (CLONTECH).
The cDNA fragment obtained by yeast two-hybrid screening encoded amino acids 1 to 252 of human EPC. To obtain the full-length EPC cDNA, we performed 5Ј and 3Ј rapid amplification of cDNA ends from human testis cDNA library by the specific nested primers using the Marathon cDNA amplification kit (CLONTECH). Both 5Ј and 3Ј rapid amplification of cDNA ends products were subcloned into the pGEM-T vector (Promega). Sequence analysis resulted in the identification of an additional 249-bp 5Ј cDNA fragment and an additional 1887-bp 3Ј cDNA fragment that included a termination codon. To generate the full-length EPC cDNA, an NcoI/XbaI fragment of pACT2-EPC (amino acids 1-252) vector that was derived from the first yeast two-hybrid screening was ligated into the NcoI/XbaI sites of 3Ј rapid amplification of cDNA ends product cloned into the pGEM-T vector.
EPcA domain region (A region, amino acids 2 to 285), EPcB domain region (B region, amino acids 280 to 496), EPcC domain and glutaminerich region (CQ region, amino acids 493 to 620), and CQ and carboxylterminal region (CQCT region, amino acids 493 to 836) (Fig. 2B) were amplified by the specific primers with a flanking EcoRI site on the 5Ј primer and an XhoI site on the 3Ј primer, using the full-length EPC cDNA as a template. The PCR products were subcloned into the pGEM-T vector (Promega) and sequenced to ensure that there were no mutations. These products were cloned into the EcoRI/XhoI sites of pACT2 vector (CLONTECH).
The pV5-HisC-GAL4BD plasmid was generated by two steps. A HindIII-EcoRI fragment of the pAS2-1 vector that contains a GAL4BD site was subcloned into the pcDNA3.1/V5-HisC vector (Invitrogen) and then the multicloning site between SfiI and EcoRI was replaced by that of the pACT2 vector. The full-length EPC cDNA or its fragments (A region, B region, CQ region, and CQCT region) were cloned in-frame into the pV5-HisC-GAL4BD plasmid. To obtain pV5-HisC-GAL4BD-RFP plasmids, a HindIII-BamHI fragment of pAS2-1 full-length RFP or pAS2-1 RFP domains was cloned into the same site of the pcDNA3.1/V5-HisC vector.
Yeast Two-hybrid Screening of RFP Interacting Proteins-The fulllength RFP cDNA was cloned into the pAS2-1 vector (CLONTECH) and used as bait to screen for its interacting proteins in a two-hybrid screen. The pAS2-1 RFP plasmid was co-transfected with human testis cDNA library (CLONTECH) into the Y190 strain of Saccharomyces cerevisiae. The transformants were plated first on selective medium lacking tryptophan and leucine, and then on selective medium lacking histidine, tryptophan, and leucine with 40 mM 3-amino-1,2,4-triazole (3-AT) (histidine "jump-start" method). From approximately 5 ϫ 10 6 independent clones, 50 colonies were found to grow on a minimal medium lacking leucine, tryptophan, and histidine, and positive for ␤-galactosidase expression. ␤-Galactosidase activity was assayed by the filter assay method according to the manufacturer's instructions (CLONTECH). After DNA isolation, these clones were further characterized by sequencing and analyzed for gene homology by the BLAST data base.
To characterize the interaction between each RFP and EPC domain in the yeast two-hybrid system, the RFP and EPC domains amplified by PCR were cloned into pAS2-1 and pACT2, respectively, and transformed into Y190. Positive interactions meet the two criteria of growth in the presence of 40 mM 3-AT and the expression of ␤-galactosidase. Measurements were performed using six independent colonies.
GAL4 Fusion Reporter-gene Targeted Repression Assay-The GAL4-binding site was amplified from the pFR-Luc vector (Stratagene) by PCR and cloned into the KpnI/SacI sites of pGL3 luciferase reporter plasmid (Promega). Serum response element (SRE), cAMP response element (CRE), and herpes simplex virus thymidine kinase minimal promoter were cloned from pSRE-SEAP or pCRE-SEAP vectors (CLON-TECH). 293 human embryo kidney cells were cultured in 24-well tissue culture plates and co-transfected with 30 ng of luciferase reporter plasmid, 30 ng of pRL-TK plasmid (Promega), and 240 ng of pCMV-GAL4 RFP or EPC fusion constructs by the LipofectAMINE method (Life Technologies, Inc.) according to the manufacturer's instructions. The cells were harvested 48 h after transfection, and luciferase assays were performed as described previously (35) . Co-transfection with the pRL-TK plasmid was used to normalize all luciferase values.
Antibodies-A synthetic peptide corresponding to the carboxyl-terminal 20 amino acids of EPC was prepared by a solid phase method and purified by high performance liquid chromatography. Rabbits were immunized with 100 g of the synthetic peptide coupled to 500 g of thyroglobulin in complete Freund's adjuvants. The anti-RFP polyclonal antibody was described previously (8) .
Coimmunoprecipitation Studies-293 cells plated in three 60-mm dishes 24 h before transfection were transfected with 2 g of pFLAG-CMV2 EPC expression vector using the LipofectAMINE method. After 48 h of incubation, cells were washed in phosphate-buffered saline (PBS) and lysed in lysis buffer (50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 20 mM MgCl 2 , 0.5% Nonidet P-40, and 1 mM sodium orthovanadate) containing 1 mM phenylmethylsulfonyl fluoride, 1 g/ml leupeptine, 1 g/ml aprotinin, 5 g/ml benzamidine, and 1 g/ml pepstatin A. 2 g of rabbit anti-RFP antibody with protein A-Sepharose (Sigma) or 2 g of mouse anti-FLAG M2 antibody (Sigma) with protein G-Sepharose (Sigma) were incubated for 4 h at 4°C and then the whole cell lysates were added and incubated for 8 h at 4°C. After washing four times in lysis buffer and twice in PBS, SDS sample buffer was added and boiled for 5 min. Samples were separated on SDS-7.5% polyacrylamide gel electrophoresis and transferred to polyvinylidene difluoride filters (Millipore). After blocking with 5% skim milk in PBS and 0.05% Tween 20, filters were cut into upper and lower strips and incubated with anti-EPC and anti-RFP polyclonal antibodies, respectively. Then peroxiase-conjugated goat anti-rabbit IgG antibodies were added and developed by the ECL Plus Western blotting detection system (Amersham Pharmacia Biotech).
Immunofluorescence and Confocal Microscopy-SW480 human colorectal adenocarcinoma cells were grown on coverslips for 24 h and fixed in 4% paraformaldehyde in PBS for 5 min at room temperature, incubated twice for 5 min in PBS, and permeabilized for 5 min in PBS with 0.1% Triton X-100. Cells were blocked with 1% bovine serum albumin in PBS. For indirect immunofluorescences, the cells were incubated with primary antibodies diluted 1:1000 and then with secondary antibodies conjugated to FITC.
In order to perform double labeling of RFP and EPC with two rabbit polyclonal antibodies, the anti-RFP antibody was conjugated to Alexa 546 using the Alexa 546 antibody labeling kit (Molecular Probes). For double staining, EPC was stained with the primary polyclonal antibody and the secondary FITC-conjugated anti-rabbit IgG antibody, followed by incubation with Alexa 546-labeled anti-RFP antibody.
For the double labeling of RFP or EPC with PML, SW480 cells were stained with mouse monoclonal anti-PML antibody (PG-M3) (Santa Cruz) and secondary FITC-conjugated anti-mouse IgG antibody, followed by incubation with Alexa 546-labeled anti-RFP antibody or anti-EPC polyclonal antibody and secondary rhodamine-conjugated antirabbit IgG antibody. After immunostaining, slides were mounted in PermaFluor (Shandon) and observed with a confocal microscope (MicroRadiance, Bio-Rad).
RESULTS

Cloning and Chromosomal Mapping of Human EPC-To
identify the interacting proteins with RFP, we performed a yeast two-hybrid screening. The full-length coding region of RFP was cloned into the pAS2-1 vector and co-transformed with a human testis Matchmaker two-hybrid library (CLON-TECH) into the yeast Y190 strain. The transformants were plated first on selective medium lacking tryptophan and leucine, and then on selective medium lacking histidine, tryptophan, and leucine with 40 mM 3-AT (histidine jump-start method). Of approximately 5 ϫ 10 6 independent clones, 50 clones were Hisϩ and ␤-galactosidase positive. Four isolated clones were identical and their inserts were 777 bp in length. The nucleotide sequence was shown to be highly homologous to the EPcA domain of Drosophila Enhancer of Polycomb (E(Pc)) gene by searching the BLAST data base. E(Pc) was identified in many species and especially the EPcA domain was the longest conserved region (29) .
To obtain the full coding sequence of human EPC, we performed the 3Ј and 5Ј rapid amplification of cDNA ends method. By using the human testis cDNA library as a template, we identified a 249-bp 5Ј cDNA. A total 270-bp untranslated sequence includes a stop codon 57-bp upstream of the first ATG codon with rough conformation to a Kozak consensus sequence. A 1887-bp 3Ј cDNA product included conserved EPcB and EPcC domains and a glutamine-rich (Qx) region, followed by a termination codon. The predicted amino acid sequence of EPC (836 amino acids) is shown in Fig. 1A . The calculated molecular mass of EPC was approximately 92 kDa. EPcA, EPcB, and EPcC domains and a Qx region are highly conserved in many species, including Drosophila, C. elegans, yeast, mouse, and human (29) . There appear to be two E(Pc) paralogues in mammals, and mouse paralogues are named Epc1 and Epc2 (29) . Although mouse Epc1 and Epc2 are about one-third of the length of the Drosophila E(Pc), all three domains are conserved (Fig. 1B) . Mouse Epc1 and Epc2 have longer (Epc1-L and Epc2-L) and shorter variants (Epc1-S and Epc2-S), and the shorter variants contain the EPcA domain only (29) (Fig. 1B) . Alignment of the deduced amino acid sequences from human EPC and mouse Epc1 clearly shows a high degree of conservation (81% amino acid identity) (Fig. 1B) .
There seem to be at least two human EPC genes named EPC1 and EPC2 that were mapped to 10p11-12 and 22q13.3, respectively (29) . By the radiation hybrid mapping method (Research Genetics, Inc.), the EPC gene that we cloned was mapped on 10p11, corresponding to the location of human EPC1 (data not shown).
Identification of Interacting Domains between RFP and
FIG. 1. Amino acid sequence of human EPC and comparison of EPC homologues in eukaryotes.
A, the deduced amino acid sequence of human EPC. EPcA, EPcB, and EPcC domains and a glutamine-rich (Qx) region that are conserved in Drosophila, mice, and human are underlined by thin, thick, double, and dotted lines, respectively. B, diagram of the protein structure of EPC homologues. The diagram is oriented with the amino-terminal on the left and the conserved EPcA, EPcB, EPcC domains, and glutamine-rich (Qx) and alanine-rich (Ax) regions are designated. % indicates the amino acid identity of each region.
EPC-In the original two-hybrid screening, the full-length RFP was shown to interact with the EPcA domain of human EPC. To further clarify their interacting domains, we cloned the different regions of RFP and EPC in-frame into pAS2-1 and pACT2 vectors, respectively (Fig. 2, A and B) . Each vector was transformed into yeast Y190, and interactions were assayed by growth on selective medium lacking histidine, tryptophan, and leucine with 40 mM 3-AT and the ␤-galactosidase activity. Each experiment was done by using six independent colonies and the results are shown in Fig. 2C . Strong interaction was detected between the RFP coiled-coil domain region (CC region) and the EPcA domain region (A region) or the CQCT region that includes the EPcC domain, glutamine-rich (Qx) region (CC region) and carboxyl-terminal region. Although the CQCT region of EPC interacted with RFP, the CQ region (C domain and Qx region) of EPC had no interacting activity (Fig. 2C) , suggesting that the carboxyl-terminal region of EPC is important for EPC-RFP binding. In contrast, the RING finger B box region (RB region) or the RFP domain (RD region) of RFP showed no or very weak interacting activity in two-hybrid assays. In addi- The association is considered positive when the two criteria of the growth in the presence of 40 mM 3-AT and the ␤-galactosidase activity were met. The positive association is graded by strong (ϩϩ), moderate (ϩ), and weak (Ϯ). Absence of the cell growth or detectable color is considered negative (-). Measurements were performed using six independent colonies. tion, the EPcB domain region (B region) had very weak interaction with any regions of RFP. These results indicate that the coiled-coil domain of RFP is important for EPC binding, and both the highly conserved EPcA domain and the carboxylterminal region of human EPC could associate with RFP.
RFP and EPC Coimmunoprecipitate in Vivo-To identify the RFP and EPC proteins, we developed polyclonal antibodies against their carboxyl-terminal regions. RFP and EPC were detected as 58-and 92-kDa proteins, respectively, in the lysates of 293 human embryo kidney cells and SW480 human colorectal adenocarcinoma cells by Western blotting (Fig. 3A) . In addition, a faint 88-kDa band of EPC was present when a longer exposure was carried out (data not shown).
In order to test whether the interaction between RFP and EPC in two-hybrid assays signifies an in vivo interaction, we performed immunoprecipitation experiments. However, the detection of RFP with EPC in coprecipitaion was impossible because the band of RFP (58 kDa) that should be recognized by the secondary anti-rabbit immunoglobulin antibody was superimposed by that of anti-EPC rabbit polyclonal antibody used for immunoprecipitation (data not shown). Thus, to overcome this problem, we transiently transfected 293 cells with the FLAGtagged form of EPC expression vector (Fig. 3A) so that EPC can be immunoprecipitated by the anti-FLAG mouse monoclonal antibody. As shown in Fig. 3B , we found coprecipitation of RFP with FLAG-EPC by using the anti-FLAG monoclonal antibody. Reciprocally, EPC was coimmunoprecipitated with RFP by the anti-RFP polyclonal antibody (Fig. 3C) . These interactions were not detected when normal mouse or rabbit immunoglobulins were used for immunoprecipitation (Fig. 3, B and C) . From these results, we concluded that EPC and RFP can form complexes in mammalian cells.
RFP and EPC Colocalize in the Nucleus-Having confirmed the association of RFP and EPC in vitro and in vivo, we next analyzed the subcellular localization of EPC in relation to that of RFP by immunofluorescence experiments. In order to determine the subcellular localization of endogenous EPC, SW480 human colorectal adenocarcinoma cells were stained with the anti-EPC polyclonal antibody by indirect immunofluorescence. As shown in Fig. 4, B, E , and H, EPC proteins were found in the nuclei of SW480 cells throughout the nucleoplasm. In addition, the brightly labeled domains and the nuclear membrane distribution were apparent in some nuclei. The size and number of nuclear domains stained with the antibody were different depending on each nuclei and several domains seemed to be attached to the nuclear membrane. Endogenous RFP was also stained by using the anti-RFP polyclonal antibody conjugated with Alexa 546 and showed the similar distribution pattern in the nuclei (Fig. 4, A, D, and G) . Superimposition of the two confocal images revealed that EPC and RFP colocalized in brightly labeled nuclear domains and nuclear membrane as visualized by the yellow color (Fig. 4, C, F, and I) . Colocalization was also detected in the less-condensed area in the nuclei. The fine granular pattern was too complex to allow analysis of any systematic colocalization (Fig. 4, C, F, and I) . Both the homogenous and concentrated distribution patterns in the nuclei were similar to those of other Polycomb group protein complexes (16) . These results suggest that RFP and EPC colocalize in the nuclei and form the nuclear structure as observed for other Polycomb group proteins.
It was previously reported that a portion of RFP colocalizes with PML within PML nuclear bodies (9) . To further characterize the subcellular localization of RFP and EPC and their association with PML nuclear bodies, the double staining of PML and RFP or EPC was carried out. Fig. 5 shows that the distribution pattern of PML detected as multiple concentrated nuclear bodies was distinct from that of RFP or EPC. Superimposition of the confocal images showed that colocalization of PML and RFP or PML and EPC seemed to be limited and most PML bodies did not colocalize with RFP or EPC in the nuclei of SW480 cells.
RFP and EPC Repress Transcription-Because of the structural similarity of RFP to RING1 which can act as a transcription repressor (16) and the association of RFP with Polycomb group protein EPC, we tested the possibility that both RFP and EPC work as transcriptional repressors. Polycomb group proteins have been found to mediate the transcriptional repression of reporter genes in mammalian cells and Drosophila embryos when they are targeted as GAL4 or LexA fusion proteins (16, 26, 36, 37) . Thus, we analyzed the ability of the GAL4-EPC or GAL4-RFP fusion protein to repress the gene activity, using different luciferase reporter constructs (Fig. 6A) .
We made four different reporter constructs containing five tandem repeats of GAL4, binding sites for transcriptional en- hancers (SRE or CRE), and SV40 promoter or herpes simplex virus-thymidine kinase minimal promoter, immediately upstream of the luciferasse gene (Fig. 6A) . After transfection into 293 cells, CRE was enhanced by 100 M forskolin for 2 h. We found that GAL4-RFP and GAL4-EPC constructs repressed the luciferase expression by approximately 75 and 30 -40%, respectively, compared with the construct with the GAL4-binding domain alone (Fig. 6B) . In addition, repressive activities of both RFP and EPC were independent of the differences of enhancers or promoters used (Fig. 6B) , suggesting that their activities could be epigenetic.
We further evaluated the activities of different RFP and EPC domains on the gene transcription. The expression vectors that include the fusion genes encoding the GAL4-binding domain and various regions of RFP or EPC (Fig. 2, A and B) were co-transfected with the luciferase reporter vector containing SRE as an enhancer and SV40 promoter. As shown in Fig. 7A , the coiled-coil and RFP domain regions repressed the luciferase expression by about 80 and 50%, respectively. The repressive activity of the RING finger B-box region was rather weak (ϳ30%). In the case of EPC, the CQCT and B regions repressed the luciferase expression by about 55 and 25%, respectively. On the other hand, the A region strongly activated the transcription (Fig. 7B) . The transactivating capacity of the EPcA domain is unique among the Polycomb group proteins and this may provide the reason why the repression by GAL4-full EPC was much weaker than that by GAL4-RFP (Fig. 6) .
DISCUSSION
Interaction and Colocalization of RFP and EPC in Nuclear
Domains-The Polycomb group genes were first identified in Drosophila as the genes that maintain the homeotic gene repression through a possible chromatin regulatory mechanism.
All Polycomb genes cloned from Drosophila have mammalian homologues, suggesting the strong conservation of this system in different species (27, 28, 38) . EPC (Enhancer of Polycomb) is known to be a unique member of the Polycomb group genes (29) . Although mutations in E(Pc), Drosophila homolog of EPC, exhibit no homeotic transformations, they enhance homeotic mutations by other Polycomb group genes (30, 31) . Mutations in EPC also function as the strong suppressors of PEV that is associated with the heterochromatin formation (33) . Polycomb group proteins form multiprotein complexes and their interacting proteins except for Pho and E(Pc) have been identified (28) . In the present study, we identified RFP as an interacting protein of EPC and showed their nuclear colocalization by immunofluorescence experiments. EPC and RFP were detected in discrete nuclear domains and largely colocalized, suggesting the functional importance of their interaction. This kind of nuclear distribution is similar to those of other Polycomb group proteins, such as HPH1, BMI1, hPc2, and RING1 (16) .
RFP was reported to associate with PML and partially colocalize in the PML nuclear bodies (9) . PML body is the nuclear matrix-associated structure that is 250 -500 nm in diameter and is present in the nuclei of most cell lines (39 -42) . Although the PML nuclear body suspected to be involved in oncogenesis and viral infection (43, 44) , its exact function remains unknown. These structures may be the sites of storage of transcription factors, the sites of transcription or the sites of RNA accumulation. La Morte et al. (45) reported that these structures correspond to the sites of incorporation of fluoresceinconjugated uridine triphosphate in nascent RNA polymerase II transcripts. It was also shown that CBP, transcription coactivator/histone acetyltransferase, is present in these nuclear structures (45 that PML nuclear body itself does not accumulate RNA and proposed that these structures may contribute to the formation of the nuclear environment for the expression of specific genes. Our study showed that RFP and EPC associate with only a limited subset of PML nuclear bodies, consistent with the previous observation (9) . Thus it seems likely that RFP is involved in the gene silencing mechanism that is different from the speculated functions of the PML nuclear body. Further study will help to determine the roles of RFP-EPC and RFP-PML association in these nuclear complexes.
RFP Acts as a Transcriptional Repressor-RFP was first identified as a gene which becomes oncogenic by rearrangement with RET proto-oncogene (1, 22, 47) . RFP is a member of the B-box RING finger family that possesses a tripartite motif consisting of a RING finger, a B-box zinc finger, and a coiledcoil domain. RFP also has a characteristic carboxyl-terminal domain called the RFP domain or B30.2-like domain (6) . The RING finger has been found in a wide variety of proteins, such as PML, BMI1/Mel18 and RING1. Among them, BMI1/Mel18 is classified as a Polycomb group protein. RING1 interacts with Poycomb group proteins (HPH, BMI1, and HPC2) and is involved in the formation of Polycomb group protein complex distinct from EED (embryonic ectoderm development)/EZH (enhancer of zeste) (17, 28, 48) . In addition, it was shown that RING1 acts as a transcriptional repressor (16) .
This study identified, for the first time, the strong transcriptional repression activity of RFP that was dependent on its coiled-coil and RFP domains. Since the coiled-coil domain and RFP domain are thought to be involved in protein-protein interactions (9, 10) , it is reasonable to speculate that the function of RFP could depend on the interaction with other nuclear proteins. In fact, consistent with this view, we found that the coiled-coil domain is strongly associated with EPC. Thus, this association may be crucial for the function of RFP as the transcriptional repressor, although it is possible that nuclear proteins other than EPC are also involved in the RFP-mediated FIG. 6 . RFP and EPC repress transcription independent of enhancer or promoter differences. A, physical map of each effector and reporter constructs. The effector plasmid was constructed by ligating GAL4-binding domain (GAL4BD) in-frame with full-length RFP or EPC cDNA. The reporter plasmids contain five tandem repeats of GAL4-binding sites (5 ϫ GAL4), followed by SRE or CRE as an enhancer and SV40 promoter or herpes simplex virus-thymidine kinase minimal promoter (Tkm). B, repressive activity of RFP and EPC. Different reporter genes were co-transfected with the GAL4-RFP or GAL4-EPC effector constructs into 293 cells. After transfection, CRE was enhanced by 100 M forskolin for 2 h. Luciferase activity in cells transfected with the plasmid containing the GAL4-binding domain alone was set at 100% and luciferase activities of cells transfected with the designated effector plasmids were expressed as percentages of control value Ϯ S.E. Each value represents a result of at least three experiments.
gene silencing by forming multiprotein complex. Furthermore, it is important to point out that RFP represses the gene transcription independent of the enhancer or promoter differences, suggesting that the RFP-mediated gene silencing may be epigenetic, cooperating with the Polycomb group proteins.
Dual Functions of EPC in Transcription-EPC is classified as a Polycomb group gene and supposed to function as a transcriptional repressor. However, this study indicated that the repressive activity of EPC is relatively weak and surprisingly, the conserved EPcA domain functions as a strong transcriptional activator. EPC was identified in many species and especially the EPcA domain was known to be as the largest conserved domain of EPC (29) .
Another Polycomb group protein, E(z), Drosophila homologue of human EZH, is also suspected to have a dual function. E(z) cannot only act in gene silencing but also be involved in the maintenance of transcriptional activity by trithorax group proteins (34) . Although E(z) associates with Esc, the Drosophila homologue of human EED, and works as the repressor (32, 49, 50), this association seems to be restricted in blastderm and early gastulation stage embryos in Drosophila (48, 51) . The double heterozygous combination of recessive loss of function mutation of E(z) and trithorax group gene ash1 alleles expresses homeotic transformation phenotypes similar to those expressed by double heterozygous combination of recessive loss of function trithorax and ash1 alleles in Drosophila (52) . E(z) encodes a SET domain that is also present in trithorax group genes (53) . These evidences suggested that E(z) may be involved in the complex formation of both the Polycomb group proteins and the trithorax group proteins, probably depending on the developmental stages. E(Pc) and E(z) are different from other polycomb group proteins because their mutations also function as Su(var)s (the suppressor of PEV) that is associated with the heterochromatin formation (29, 32, 33) . These findings suggest that E(Pc)/EPC and E(z)/EZH have an additional function different from the function of other Polycomb group proteins.
It is not clarified how the EPcA domain acts as a transactivator. It is possible to speculate that the EPcA domain itself has the transcription activating function or this domain binds another transactivator such as trithorax group proteins. In this respect, it is interesting to note that mouse homologues, Epc1 and Epc2, have longer (Epc1-L and Epc2-L) and shorter (Epc1-S and Epc2-S) forms (29) . Epc1-L and Epc2-L contain the EPcA, EPcB, and EPcC domains and the glutamine-rich region, whereas Epc1-S and Epc2-S have the EPcA domain and the alanine-rich region only (Fig. 1B) . Thus, we speculate that Epc1-S and Epc2-S could function primarily as the transcription activator like trithrax group proteins, whereas Epc1-L and Epc2-L can function as the repressor like Polycomb group proteins rather than the transactivator. In addition, weak repressive function of human EPC that we observed may be due to the presence of the EpcA domain.
In summary, we found that RFP could function as the strong transcription repressor in mammalian cells. The fact that RFP and EPC associate and mostly colocalize in the nucleus suggests that EPC may be involved in the epigenetic gene silencing mediated by RFP. In addition, EPC appears to have quite different functions depending on each domain, and especially the conserved EPcA domain acts as the transcriptional activator. Further study will provide new insights into possible unique roles of EPC and RFP in the gene silencing as well as the transactivation that are important for cell growth and/or differentiation.
